An Open-Label, Fixed-Sequence, 2-Period Study to Determine the Effect of Ketoconazole on the Pharmacokinetics of GDC-0980
Phase of Trial: Phase I
Latest Information Update: 10 Jun 2016
At a glance
- Drugs Apitolisib (Primary) ; Ketoconazole
- Indications Advanced breast cancer; Endometrial cancer; Non-Hodgkin's lymphoma; Renal cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors Genentech
- 09 Mar 2013 Results presented at the 114th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 18 Jul 2012 Actual initiation date (Nov 2011) added as reported by ClinicalTrials.gov.
- 18 Jul 2012 Actual end date (Feb 2012) added as reported by ClinicalTrials.gov.